Koninklijke Philips N.V.
NYSE:PHGMedical - Devices
+$0.57 today
- Market cap
- $29.11B
- Beta
- 0.93
- P/E (TTM)
- 23.1
- EPS (TTM)
- $1.02
- Dividend yield
- 3.62%
Volume 1.45M
Average 1.17M
PHG Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Koninklijke Philips N.V.NYSE: PHG
Other Current Assets · Q2 FY2026 · quarter ended Jun 2026
Other current assets rises 7.1% from a year ago
Other current assets stood at €728M at the end of Q2 FY2026, up 7.1% from a year earlier and down 6.2% from the prior quarter. Over 3 fiscal years it compounded at +54.5% a year.
Context
- Other current assets amounted to 2.7% of total assets at the end of Q2 FY2026, up 0.1 pp from a year earlier.
- Other current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current assets keeps rising in the next quarterly balance sheet after a +7.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
EUR · from the balance sheet
- Latest · FY2025
- 738M EUR
- Year-over-year change
- +44.4%
- 4-year CAGR
- +53.8%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 738M | +44.4% |
| FY2024 | 2024-12-31 | 511M | +296.1% |
| FY2023 | 2023-12-31 | 129M | -35.5% |
| FY2022 | 2022-12-31 | 200M | +51.5% |
| FY2021 | 2021-12-31 | 132M | — |
Other Current Assets vs competitors
How PHG compares with its peers on the latest reported figures
- Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +7.1% is the 6th highest of 10, against a peer median of +24.0%.
- Other current assets amounts to 2.7% of total assets for PHG, versus a peer median of 1.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $15.59B USD | +69.2% | +7.0% | 16.7% | |
| Jun 2026 | $3B USD | +32.7% | -0.3% | 2.7% | |
| Jun 2026 | $760M USD | +24.0% | -7.4% | 1.7% | |
| Jun 2026 | €728M EUR | +7.1% | +54.5% | 2.7% | |
| Jun 2026 | $457.39M USD | +178.0% | +36.5% | 5.1% | |
| Sep 2026 | $58.7M USD | +32.1% | -34.0% | 2.2% | |
| Mar 2026 | $1.63M USD | +5.2% | +96.1% | 1.4% | |
| Mar 2026 | $1.52M USD | -31.2% | -22.7% | 1.5% | |
| Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| Dec 2025 | -$99M USD | -222.2% | — | 0.9% | |
| Peer median (excluding PHG) | — | +24.0% | -0.3% | 1.7% | |
Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.3B | 1.17B | 1.87B | 2.4B | 2.79B |
| Short-term Investments | 2M | 11M | 3M | 2M | 0 |
| Net Receivables | 4.29B | 4.65B | 4.25B | 3.67B | 3.53B |
| Inventory | 3.45B | 4.05B | 3.49B | 3.2B | 2.87B |
| Other Current Assets | 132M | 200M | 129M | 511M | 738M |
| Total Current Assets | 10.35B | 10.26B | 9.94B | 10.02B | 9.93B |
| Property, Plant & Equipment (Net) | 2.7B | 2.64B | 2.48B | 2.45B | 2.22B |
| Goodwill | 10.64B | 10.24B | 9.88B | 10.38B | 9.27B |
| Intangible Assets | 3.65B | 3.53B | 3.19B | 2.98B | 2.57B |
| Long-term Investments | 1.06B | 1.2B | 1B | 889M | 852M |
| Tax Assets | 2.22B | 2.45B | 2.63B | 1.92B | 0 |
| Other Non-current Assets | 355M | 381M | 287M | 332M | 2.1B |
| Total Non-current Assets | 20.61B | 20.43B | 19.47B | 18.95B | 17.01B |
| Total Assets | 30.96B | 30.69B | 29.41B | 28.98B | 26.94B |
| Account Payables | 1.87B | 1.97B | 1.92B | 1.83B | 1.93B |
| Short-term Debt | 53M | 95M | 123M | 224M | 1.15B |
| Tax Payables | 318M | 155M | 212M | 186M | 0 |
| Deferred Revenue | 1.49B | 1.7B | 1.81B | 1.7B | 0 |
| Other Current Liabilities | 1.39B | 1.95B | 1.93B | 2.19B | 2.82B |
| Total Current Liabilities | 7.45B | 7.93B | 8.29B | 8.14B | 7.51B |
| Long-term Debt | 4.77B | 6.17B | 6.1B | 6.19B | 6.93B |
| Deferred Tax Liabilities | 83M | 91M | 71M | 81M | 0 |
| Deferred Revenue (Non-current) | 446M | 515M | 469M | 431M | 0 |
| Other Non-current Liabilities | 2.77B | 1.85B | 1.56B | 1.23B | 1.51B |
| Total Non-current Liabilities | 9.04B | 9.47B | 9.06B | 8.79B | 8.45B |
| Total Liabilities | 16.49B | 17.41B | 17.35B | 16.93B | 15.96B |
| Common Stock | 177M | 178M | 183M | 188M | 193M |
| Retained Earnings | 9.34B | 6.83B | 5.4B | 3.65B | 3.58B |
| Accumulated OCI | 748M | 1.49B | 879M | 1.93B | 274M |
| Other Stockholders Equity | 0 | 1M | (1M) | 0 | 0 |
| Minority Interest | 36M | 34M | 33M | 37M | 32M |
| Total Equity | 14.48B | 13.28B | 12.06B | 12.04B | 10.99B |
| Total Debt | 6.05B | 7.34B | 7.29B | 7.49B | 8.09B |
| Net Debt | 3.74B | 6.17B | 5.42B | 5.09B | 5.29B |
Koninklijke Philips N.V.
NYSE:PHG
Intrinsic Alpha fair value
Locked
Current Price
$29.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.